These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8582162)
1. [Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening]. Röher HD; Simon D; Goretzki PE; Höppner W; Lederbogen S; Seppel T Chirurg; 1995 Dec; 66(12):1196-202. PubMed ID: 8582162 [TBL] [Abstract][Full Text] [Related]
2. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related]
3. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature]. de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023 [TBL] [Abstract][Full Text] [Related]
4. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
5. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES). Niederle B; Sebag F; Brauckhoff M Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502 [TBL] [Abstract][Full Text] [Related]
6. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Frilling A; Dralle H; Eng C; Raue F; Broelsch CE Surgery; 1995 Dec; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529 [TBL] [Abstract][Full Text] [Related]
7. Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2. Frilling A; Höppner W; Eng C; Mulligan L; Raue F; Broelsch CE J Mol Med (Berl); 1995 May; 73(5):229-33. PubMed ID: 7670926 [TBL] [Abstract][Full Text] [Related]
8. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617 [TBL] [Abstract][Full Text] [Related]
9. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene]. Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Wells SA; Skinner MA Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056 [TBL] [Abstract][Full Text] [Related]
11. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis. Szinnai G; Meier C; Komminoth P; Zumsteg UW Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing. Lau GS; Lang BH; Lo CY; Tso A; Garcia-Barcelo MM; Tam PK; Lam KS Hong Kong Med J; 2009 Oct; 15(5):326-31. PubMed ID: 19801688 [TBL] [Abstract][Full Text] [Related]
16. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265 [TBL] [Abstract][Full Text] [Related]
17. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia. Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548 [TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274 [TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar. Zirie M; Mohammed I; El-Emadi M; Haider A Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764 [TBL] [Abstract][Full Text] [Related]
20. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC). Niccoli-Sire P; Murat A; Baudin E; Henry JF; Proye C; Bigorgne JC; Bstandig B; Modigliani E; Morange S; Schlumberger M; Conte-Devolx B Eur J Endocrinol; 1999 Nov; 141(5):468-74. PubMed ID: 10576762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]